197 related articles for article (PubMed ID: 14770020)
1. Cigarette smoking exacerbates and its cessation ameliorates renal injury in type 2 diabetes.
Chuahirun T; Simoni J; Hudson C; Seipel T; Khanna A; Harrist RB; Wesson DE
Am J Med Sci; 2004 Feb; 327(2):57-67. PubMed ID: 14770020
[TBL] [Abstract][Full Text] [Related]
2. Continued smoking exacerbates but cessation ameliorates progression of early type 2 diabetic nephropathy.
Phisitkul K; Hegazy K; Chuahirun T; Hudson C; Simoni J; Rajab H; Wesson DE
Am J Med Sci; 2008 Apr; 335(4):284-91. PubMed ID: 18414067
[TBL] [Abstract][Full Text] [Related]
3. Cigarette smoking and increased urine albumin excretion are interrelated predictors of nephropathy progression in type 2 diabetes.
Chuahirun T; Khanna A; Kimball K; Wesson DE
Am J Kidney Dis; 2003 Jan; 41(1):13-21. PubMed ID: 12500217
[TBL] [Abstract][Full Text] [Related]
4. Cigarette smoking predicts faster progression of type 2 established diabetic nephropathy despite ACE inhibition.
Chuahirun T; Wesson DE
Am J Kidney Dis; 2002 Feb; 39(2):376-82. PubMed ID: 11840380
[TBL] [Abstract][Full Text] [Related]
5. Cigarette Smoking Attenuates Kidney Protection by Angiotensin-Converting Enzyme Inhibition in Nondiabetic Chronic Kidney Disease.
Roehm B; Simoni J; Pruszynski J; Wesson DE
Am J Nephrol; 2017; 46(4):260-267. PubMed ID: 28930715
[TBL] [Abstract][Full Text] [Related]
6. Smoking and progression of diabetic nephropathy in patients with type 1 diabetes.
Feodoroff M; Harjutsalo V; Forsblom C; Thorn L; Wadén J; Tolonen N; Lithovius R; Groop PH
Acta Diabetol; 2016 Aug; 53(4):525-33. PubMed ID: 26668013
[TBL] [Abstract][Full Text] [Related]
7. Microalbuminuria and hypertension with focus on type 1 and type 2 diabetes.
Mogensen CE
J Intern Med; 2003 Jul; 254(1):45-66. PubMed ID: 12823642
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin-converting enzyme inhibitors and probucol suppress the time-dependent increase in urinary Type IV collagen excretion of Type II diabetes mellitus patients with early diabetic nephropathy.
Nishimura M; Sasaki T; Ohishi A; Oishi M; Kono S; Totani Y; Kato Y; Noto Y; Misaki S; Higashi K; Shimada F; Wakasugi H; Inoue K; Hoshiyama Y; Yamada K
Clin Nephrol; 2001 Aug; 56(2):96-103. PubMed ID: 11522101
[TBL] [Abstract][Full Text] [Related]
9. The independent relationship between creatinine clearance, microalbuminuria and circadian blood pressure levels in newly diagnosed essential hypertensive and type 2 diabetic patients.
Afsar B; Elsurer R
J Diabetes Complications; 2012; 26(6):531-5. PubMed ID: 22795337
[TBL] [Abstract][Full Text] [Related]
10. Long-term effects of angiotensin-converting enzyme inhibition and metabolic control in hypertensive type 2 diabetic patients.
Chan JC; Ko GT; Leung DH; Cheung RC; Cheung MY; So WY; Swaminathan R; Nicholls MG; Critchley JA; Cockram CS
Kidney Int; 2000 Feb; 57(2):590-600. PubMed ID: 10652036
[TBL] [Abstract][Full Text] [Related]
11. Treatment of microalbuminuria in patients with type 2 diabetes mellitus.
Jerums G; MacIsaac RJ
Treat Endocrinol; 2002; 1(3):163-73. PubMed ID: 15799209
[TBL] [Abstract][Full Text] [Related]
12. Periostin as a tissue and urinary biomarker of renal injury in type 2 diabetes mellitus.
Satirapoj B; Tassanasorn S; Charoenpitakchai M; Supasyndh O
PLoS One; 2015; 10(4):e0124055. PubMed ID: 25884625
[TBL] [Abstract][Full Text] [Related]
13. Effects of smoking and its cessation on creatinine- and cystatin C-based estimated glomerular filtration rates and albuminuria in male patients with type 2 diabetes mellitus: the Fukuoka Diabetes Registry.
Ohkuma T; Nakamura U; Iwase M; Ide H; Fujii H; Jodai T; Kaizu S; Kikuchi Y; Idewaki Y; Sumi A; Hirakawa Y; Kitazono T
Hypertens Res; 2016 Oct; 39(10):744-751. PubMed ID: 27250568
[TBL] [Abstract][Full Text] [Related]
14. Albuminuria: a target for treatment of type 2 diabetic nephropathy.
de Zeeuw D
Semin Nephrol; 2007 Mar; 27(2):172-81. PubMed ID: 17418686
[TBL] [Abstract][Full Text] [Related]
15. Renal structure in normoalbuminuric and albuminuric patients with type 2 diabetes and impaired renal function.
Ekinci EI; Jerums G; Skene A; Crammer P; Power D; Cheong KY; Panagiotopoulos S; McNeil K; Baker ST; Fioretto P; Macisaac RJ
Diabetes Care; 2013 Nov; 36(11):3620-6. PubMed ID: 23835690
[TBL] [Abstract][Full Text] [Related]
16. Course of renal function in type 2 diabetic patients with abnormalities of albumin excretion rate.
Nosadini R; Velussi M; Brocco E; Bruseghin M; Abaterusso C; Saller A; Dalla Vestra M; Carraro A; Bortoloso E; Sambataro M; Barzon I; Frigato F; Muollo B; Chiesura-Corona M; Pacini G; Baggio B; Piarulli F; Sfriso A; Fioretto P
Diabetes; 2000 Mar; 49(3):476-84. PubMed ID: 10868971
[TBL] [Abstract][Full Text] [Related]
17. Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia.
Ravid M; Brosh D; Ravid-Safran D; Levy Z; Rachmani R
Arch Intern Med; 1998 May; 158(9):998-1004. PubMed ID: 9588433
[TBL] [Abstract][Full Text] [Related]
18. Renal function preservation in type 2 diabetes mellitus patients with early nephropathy: a comparative prospective cohort study between primary health care doctors and a nephrologist.
Martínez-Ramírez HR; Jalomo-Martínez B; Cortés-Sanabria L; Rojas-Campos E; Barragán G; Alfaro G; Cueto-Manzano AM
Am J Kidney Dis; 2006 Jan; 47(1):78-87. PubMed ID: 16377388
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of diabetic nephropathy in primary care type 2 diabetic patients with hypertension: data from the Korean Epidemiology Study on Hypertension III (KEY III study).
Yang CW; Park JT; Kim YS; Kim YL; Lee YS; Oh YS; Kang SW
Nephrol Dial Transplant; 2011 Oct; 26(10):3249-55. PubMed ID: 21372264
[TBL] [Abstract][Full Text] [Related]
20. Effect of smoking on the prevalence of albuminuria in Japanese men with non-insulin-dependent diabetes mellitus.
Ikeda Y; Suehiro T; Takamatsu K; Yamashita H; Tamura T; Hashimoto K
Diabetes Res Clin Pract; 1997 Apr; 36(1):57-61. PubMed ID: 9187416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
